Asia
ApicHope Pharmaceutical Signs Clinical Trial Contract with Boji Medical Technology for Obesity Drug; Shares Rise 4%
ApicHope Pharmaceutical (SHE:300723) subsidiary Guangzhou ApicHope will sign a clinical research commissioning contract with Boji Medical Technology (SHE:300404) for 6.5 million yuan, according to a Saturday disclosure to the Shenzhen Stock Exchange.Boji will perform clinical research for the APH04935 tablets for weight management and obesity.Shares rose 4% during afternoon trading on Monday.
SHE:300404SHE:300723
